MRNA Earnings Moderna
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -3.40 | 2026-05-01 | 10-Q |
| FY 2025 | 2025-12-31 | -7.26 | 2026-02-20 | 10-K |
| Q3 2025 | 2025-09-30 | -5.15 | 2025-11-06 | 10-Q |
| Q2 2025 | 2025-06-30 | -4.64 | 2025-08-01 | 10-Q |
| Q1 2026 | 2025-03-31 | -2.52 | 2026-05-01 | 10-Q |
| FY 2025 | 2024-12-31 | -9.28 | 2026-02-20 | 10-K |
| Q3 2025 | 2024-09-30 | -6.37 | 2025-11-06 | 10-Q |
| Q2 2025 | 2024-06-30 | -6.41 | 2025-08-01 | 10-Q |
| Q1 2025 | 2024-03-31 | -3.07 | 2025-05-01 | 10-Q |
| FY 2025 | 2023-12-31 | -12.33 | 2026-02-20 | 10-K |
| Q3 2024 | 2023-09-30 | -12.89 | 2024-11-07 | 10-Q |
| Q2 2024 | 2023-06-30 | -3.39 | 2024-08-01 | 10-Q |
| Q1 2024 | 2023-03-31 | 0.19 | 2024-05-02 | 10-Q |
| FY 2024 | 2022-12-31 | 20.12 | 2025-02-21 | 10-K |
| Q3 2023 | 2022-09-30 | 16.46 | 2023-11-03 | 10-Q |
| Q2 2023 | 2022-06-30 | 13.85 | 2023-08-03 | 10-Q |
| Q1 2023 | 2022-03-31 | 8.58 | 2023-05-04 | 10-Q |
| FY 2023 | 2021-12-31 | 28.29 | 2024-02-23 | 10-K |
| Q3 2022 | 2021-09-30 | 17.00 | 2022-11-03 | 10-Q |
| Q2 2022 | 2021-06-30 | 9.30 | 2022-08-03 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.